Pain.
Conditions
Interventions
Intervention 1: Intra-peritoneal injection of 30 cc Bupivacaine 0.25%. Intervention 2: Intra-peritoneal injection of 30 cc Bupivacaine 0.25% plus 2 milligram Morphine. Intervention 3: Intr-peritoneal
Treatment - Drugs
Intra-peritoneal injection of 30 cc Bupivacaine 0.25%
Intra-peritoneal injection of 30 cc Bupivacaine 0.25% plus 2 milligram Morphine
Intr-peritoneal injection of 200 milligram Hydrocortisone
Sponsors
Vice chancellor for research, Golestan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients candidate for laparoscopic cholecystectomy; age between 20 to 50 years; Class I and II ASA Exclusion criteria: Opioid consumption during 24 hours before the operation; Chronic fatigue syndrome; Inability to report pain; Steroid therapy; Neurologic diseases; Taking NSAIDs; Acute cholecystitis; Other kind of cholelithiasis (other than gall bladder); Hematological disorders; Neuromuscular diseases
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain reduction. Timepoint: Hours 0.5-1-4-8-16 after the surgery. Method of measurement: VAS scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Time of bowel function onset. Timepoint: Hours 6-12-24 after the surgery. Method of measurement: Personal report.;Nausea and vomiting. Timepoint: Hours 0.5-1-4-8-12-16 after the surger. Method of measurement: Personal report.;Time of oral nutriton. Timepoint: Hours 6-12-24 after the surgery. Method of measurement: Personal report.;Time of movement without help. Timepoint: Hours 6-12-24 after the surgery. Method of measurement: Personal report. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Maryam Zahedi Tabarestani
Golestan University of Medical Sciences
Outcome results
None listed